Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.051 0.5
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.5
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.033 0.5
mRNA tigecycline CTRPv2 pan-cancer AAC 0.032 0.5
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC 0.023 0.5
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.021 0.5
mRNA Y-39983 GDSC1000 pan-cancer AAC -0.021 0.5
Download CSV